Literature DB >> 8532421

Repeatedly positive human immunodeficiency virus type 1 DNA polymerase chain reaction in human immunodeficiency virus-exposed seroreverting infants.

S S Bakshi1, S Tetali, E J Abrams, M O Paul, S G Pahwa.   

Abstract

Three human immunodeficiency virus type 1 (HIV-1)-exposed children who had repeatedly positive DNA polymerase chain reaction (PCR) tests for HIV in > or = 5 samples before seroreversion to HIV-negative status are reported. The children belong to a cohort of 210 infants who were born to HIV-infected mothers and were tested at intervals of 1 to 3 months by HIV viral culture, PCR, and p24 antigen; only the PCR was positive in > or = 5 samples in the children reported here. Their clinical features were indistinguishable from other seroreverters. All three children had a transient drop in CD4:CD8 ratio to < 1.0. The transiently positive DNA PCR in HIV-exposed infants may indicate either that HIV infection was eliminated by a strong host immune response or that infection was caused by an attenuated/defective strain of virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8532421     DOI: 10.1097/00006454-199508000-00002

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

Review 1.  Mechanisms of resistance to HIV infection.

Authors:  W A Paxton; R A Koup
Journal:  Springer Semin Immunopathol       Date:  1997

2.  Repeated false positive HIV DNA PCR in an exposed infant.

Authors:  S S Mathai; K M Adhikari
Journal:  Med J Armed Forces India       Date:  2013-10-03

3.  Are infants unique in their ability to be "functionally cured" of HIV-1?

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

4.  Absence of detectable HIV-1 viremia after treatment cessation in an infant.

Authors:  Deborah Persaud; Hannah Gay; Carrie Ziemniak; Ya Hui Chen; Michael Piatak; Tae-Wook Chun; Matthew Strain; Douglas Richman; Katherine Luzuriaga
Journal:  N Engl J Med       Date:  2013-10-23       Impact factor: 91.245

5.  Early infant human immunodeficiency virus type 1 detection suitable for resource-limited settings with multiple circulating subtypes by use of nested three-monoplex DNA PCR and dried blood spots.

Authors:  Qi Zhang; Linhong Wang; Yan Jiang; Liwen Fang; Pinliang Pan; Shuangyan Gong; Jun Yao; Yi-Wei Tang; Sten H Vermund; Yujiang Jia
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

6.  Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals.

Authors:  Tuofu Zhu; Lawrence Corey; Yon Hwangbo; Jean M Lee; Gerald H Learn; James I Mullins; M Juliana McElrath
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

7.  Indeterminate and discrepant rapid HIV test results in couples' HIV testing and counselling centres in Africa.

Authors:  Debrah I Boeras; Nicole Luisi; Etienne Karita; Shila McKinney; Tyronza Sharkey; Michelle Keeling; Elwyn Chomba; Colleen Kraft; Kristin Wall; Jean Bizimana; William Kilembe; Amanda Tichacek; Angela M Caliendo; Eric Hunter; Susan Allen
Journal:  J Int AIDS Soc       Date:  2011-04-08       Impact factor: 5.396

8.  HLA A*32 is associated to HIV acquisition while B*44 and B*53 are associated with protection against HIV acquisition in perinatally exposed infants.

Authors:  Linda Mouafo Mekue; Céline Nguefeu Nkenfou; Elvis Ndukong; Leaticia Yatchou; Beatrice Dambaya; Marie-Nicole Ngoufack; Joel Kadji Kameni; Jules-Roger Kuiaté; Alexis Ndjolo
Journal:  BMC Pediatr       Date:  2019-07-23       Impact factor: 2.125

9.  Absence of seroreversion in 80 HAART-treated HIV-1 seropositive patients with at least five-years undetectable plasma HIV-1 viral load.

Authors:  Marion Cornelissen; Suzanne Jurriaans; Jan M Prins; Margreet Bakker; Antoinette C van der Kuyl
Journal:  AIDS Res Ther       Date:  2006-02-16       Impact factor: 2.250

10.  Serodeconversion of HIV antibody-positive AIDS patients following treatment with V-1 Immunitor.

Authors:  Orapun Metadilogkul; Vichai Jirathitikal; Aldar S Bourinbaiar
Journal:  J Biomed Biotechnol       Date:  2008-10-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.